New Delhi: India hopes to get the dose of Johnson & Johnson Covid-19’s first vaccine from next month, filled and resolved in India by US drug maker partners, sources with knowledge about the issue to Reuters on Monday.
It can receive as many as 43.5 million doses of single-shot vaccine in October, the source said – a big step towards helping India fulfill its target produces more than 300 million doses in that month.
India is the largest vaccine manufacturing center in the world.
After fulfilling his own needs, he planned to continue exports, which was stopped in April.
The Indian drug regulator last month gave emergency authorization to the J & J vaccine, both imported or locally filled and resolved by Indian partners J & J, biologically E.
However, the Indian government has not signed an offer agreement with J & J.
“Dosage J & J It is expected that from next month, “said the source, who refused to be called as he was not authorized to speak with the media.
“Bio E will formulate and make 5 ml bottle.” The Ministry of India’s health did not immediately respond to a comment request.
A spokesman for J & J India said “prematurely for us to speculate about our vaccine delivery time”.